Search results

In the high-stakes arena of cancer drug development, SU212 was engineered as a safer twist on podophyllotoxin—a toxic killer designed to halt rogue cell division. Yet in a twist worthy of scientific serendipity, it veered off course, bypassing its intended target entirely and stumbling upon a superior mark. SU212 starves aggressive cancers, slashing growth with scant harm to healthy cells. This off-script pivot echoes drug history's happy accidents. Let's talk about how luck can lead to scientific breakthroughs.

Following the emergence of COVID-19, "follow the science" became a stark ideological divide that pitted one American against another. This partisan framing weaponized the scientific method instead of letting it solve a critical public-health crisis. Is it time to abandon this unhelpful slogan and rethink our broken understanding of science?

CMS tried to turn diabetes prevention into a coach-led lifestyle “playlist” for Medicare, aiming at achieving at least 5% weight loss and staving off Type II diabetes. On paper, MDPP fits MAHA’s preventive-care ambitions perfectly: broader eligibility and more types of community providers. But the program kept missing the beat where it mattered most—tiny enrollment, uneven geographic access, and leaving the evidence for real-world diabetes prevention frustratingly inconclusive.

American primary-care doctors can prescribe methadone for pain—but not for addiction. Meanwhile, their counterparts in Australia, Canada, and the UK have used methadone to treat addiction for over 50 years. A new randomized controlled trial shows they were right the whole time.

Fentanyl overdoses can happen in minutes, and the usual tools respond after the damage is already underway. A proposed vaccine tries a different approach: keep fentanyl tied up in the bloodstream so less reaches the brain. According to an article in Wired, a first human trial is coming soon, which should tell us whether the rodent results hold up in people.

Anti-vaxxers have found a powerful new weapon: the plaintiffs’ bar. Armed with repurposed federal claims and fueled by political momentum, they’re launching lawsuits that threaten a century of legal deference to vaccines — and courts are beginning to split, inviting Supreme Court intervention.

A proposed CMS rule hints that some Medicare plans could cover certain legal CBD products, bringing cannabinoids a step closer to “real medicine” status for seniors. But even as that possibility opens, Congress is simultaneously considering a hemp redefinition that could close off access to many of those same products.

This essay is the second in a two-part series examining the CDC’s revised autism–vaccine messaging and the broader politicization of CDC science. While Part 1 focused on the November 19, 2025 change to the CDC’s “Autism and Vaccines” page and its impact on families, clinicians, and vaccine confidence, Part 2 traces the longer history of political interference at the agency and proposes structural reforms to help restore trust.

Celebrities can turn almost anything into a must-try beauty treatment—even facials with shock-value nicknames like “salmon sperm” and “penis” facials. But behind the viral labels are lab-made ingredients and marketing, and the real question is simple: do they work well enough to justify the hype and cost? The article argues the effects look modest compared with more proven options—and that sun protection still beats most “miracle” fixes.

In the final days of the Biden Administration, the EPA locked in a formaldehyde risk evaluation built on the Agency’s long-controversial IRIS assessment—only for the next EPA to do something genuinely unexpected. Rather than tweak the rule and keep IRIS at the center, the Agency recalculated key benchmarks using alternative science, signaling a potential turning point in how chemical risks get judged. If that shift holds, it could loosen IRIS’s grip on rulemaking far beyond formaldehyde.

The CDC’s Advisory Committee on Immunization Practices' move away from recommending routine hepatitis B vaccination at birth is being treated as either a triumph of “medical freedom” or a looming public-health disaster. Strip away the heat, and the situation is simpler: hepatitis B is still dangerous, the newborn vaccine is still remarkably safe, and the real-world care system is imperfect. The question isn’t whether parents can choose—they always could—it’s whether policy should keep nudging toward the choice that prevents the most avoidable infections.

Scromiting” is a grim slang term for the severe nausea and vomiting that can come with cannabinoid hyperemesis syndrome (CHS), a complication linked to long-term heavy cannabis use. As ER clinicians report seeing more cases, the condition is forcing a fresh look at the gap between marijuana’s “harmless” reputation and its real-world risks.

Every year, as the holidays approach, headlines warn of “holiday blues” and Seasonal Affective Disorder—but that familiar narrative often leans more on anecdotes than on solid evidence. Depression doesn’t reliably rise with less winter sunlight or the holidays. While a seasonal slump is real for some, the idea that many Americans are destined for holiday misery isn’t well supported.

The CMS star ratings began as faint points of light helping patients navigate an increasingly complex galaxy of healthcare options. But over time, those points of light became financial Novas, reshaping the orbits of federal dollars across insurers, physicians, and health systems. Now, they burn at the center of who gets to define “quality” in American healthcare, and who is illuminated or eclipsed by its glow.

With all that's going on nowadays, do we really need to worry about chemicals in our underwear? Let's take a *brief* look.

If you're a parent of young children, chances are the Elf on the Shelf comes to your home during the holiday season. You give it a name, prop it on a shelf, and instantly you have Santa’s personal surveillance drone watching your family's every move. But how exactly does the little tyrant do it-- watch our every move and report back to Santa, that is? We'll help you explain the fun, light-hearted science to your curious kids.

If you’re in your 40s, shingles isn’t just an older-adult problem—it’s the chickenpox virus waking up decades later, and it can hit you now. Getting it before age 50 significantly raises your chances of painful repeat episodes later in life, with burning, electric-shock pain that can linger for months or even years. The good news: the shingles vaccine is safe, effective, and increasingly available (and covered) before 50.

While dogs have long been celebrated for easing stress and boosting companionship, science is beginning to explore a more unexpected influence: the microbes they share with us. A new study suggests that some of the mental-health benefits seen in teens who grow up with dogs might be carried not by wagging tails, but microscopic hitchhikers.

The search for answers in autism is deeply emotional, and unscrupulous actors know it. Miracle Mineral Solution exploits that emotion by offering false hope in the form of a potent industrial bleach. This article unpacks the science and exposes the dangers behind this misleading—and potentially harmful—“treatment.”

This essay examines how recent political intervention has reshaped the CDC’s public messaging on vaccines and autism. In Part 1, I explain why the scientific evidence on this topic has not changed—and why the CDC’s newly revised webpage represents a step backward for public health communication. Part 2 will explore how growing political influence has eroded trust in the agency over time.

RCTs, randomized controlled trials, are often hailed as the ultimate test of whether an intervention works, yet relying solely on RCTs leaves significant blind spots in science and public health. Ethics, cost, and real-world complexity sometimes make RCTs impossible or uninformative, requiring other methods to fill in the gaps. A complete picture of evidence comes only from weaving together many types of studies.

The new Lancet Series on ultra-processed foods (UPFs) draws on decades of global data, mechanistic evidence, and more than 100 prospective studies to argue that UPFs constitute a dietary pattern actively displacing traditional food cultures and driving chronic disease worldwide. Yet the UPF/NOVA framework is itself contested, a point worth keeping in mind as the article advances its arguments.

Joshua Lederberg, Nobel laureate and president of Rockefeller University, is well known in biology circles.  Not so his wife, Dr. Esther Lederberg – whose name was drowned in the annals of the history of biology. And yet her work is critical to the practice of cutting-edge medicine and serves as a scaffold for modern genetic discoveries.

Across four very different stories runs a common thread: our deepening struggle to preserve authentic human connection in a world being reshaped by age, loss, and advancing technology. Together, they ask whether connection can be digitized, whether memory can be simulated, and whether creativity can survive automation, reminding us that the most meaningful bonds are still forged in the living, breathing presence of real people.

"You have cancer." It's a life-changing (and sometimes life-ending) development—a horrible piece of news no one is really ever prepared to receive. Are there better and worse ways to react? Can you do anything to improve your prognosis? Dr. Chuck Dinerstein answers these questions while recounting his harrowing experience with prostate cancer.